CPT® Code 82960

1. Indications

G6PD screening is indicated for several specific conditions and circumstances, particularly in populations at risk for G6PD deficiency. The following are the primary indications for performing this test:

• Newborn Screening G6PD screening is commonly performed on newborns to identify those who may have a deficiency, which can lead to prolonged jaundice and other complications.
• Family History Individuals with a family history of G6PD deficiency or related hemolytic anemia may be screened to assess their risk.
• Symptoms of Hemolytic Anemia Patients presenting with symptoms indicative of hemolytic anemia, such as fatigue, pallor, or jaundice, may require G6PD testing to determine if a deficiency is the underlying cause.
• Exposure to Triggers Individuals who have been exposed to known triggers of hemolysis, such as certain medications, foods (e.g., fava beans), or infections, may be screened to evaluate their G6PD status.

2. Procedure

The procedure for G6PD screening involves several key steps to ensure accurate results. The following outlines the procedural steps:

• Step 1: Patient Preparation Prior to the blood draw, the patient should be informed about the procedure and any necessary preparations, such as fasting or avoiding certain medications, if applicable.
• Step 2: Blood Sample Collection A blood sample is obtained from the patient, typically through venipuncture. The sample is collected in a suitable container to prevent contamination and ensure the integrity of the specimen.
• Step 3: Laboratory Testing The collected blood sample is sent to a laboratory where it undergoes testing. The Beutler fluorescent spot test is utilized to screen for the presence of G6PD in the blood. This test involves adding a substrate to the blood sample and measuring the fluorescence, which indicates the activity level of the enzyme.
• Step 4: Result Interpretation Once the testing is complete, the laboratory analyzes the results. A normal result indicates adequate levels of G6PD, while a low level suggests a deficiency, which may require further clinical evaluation and management.

3. Post-Procedure

After the G6PD screening procedure, there are several considerations for patient care and follow-up. Patients may experience minor discomfort at the site of the blood draw, which typically resolves quickly. It is important to provide patients with information regarding the expected timeline for receiving results, as well as any necessary follow-up actions based on the outcome of the test. If a deficiency is detected, healthcare providers should discuss potential lifestyle modifications, avoidance of known triggers, and any further testing or monitoring that may be required to manage the patient's health effectively. Additionally, education on recognizing symptoms of hemolytic anemia and when to seek medical attention is crucial for patients diagnosed with G6PD deficiency.